Exact Mass: 319.1267

Exact Mass Matches: 319.1267

Found 106 metabolites which its exact mass value is equals to given mass value 319.1267, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Norfloxacin

1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid

C16H18FN3O3 (319.1332)


Norfloxacin is only found in individuals that have used or taken this drug. It is a synthetic fluoroquinolone (fluoroquinolones) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA gyrase. [PubChem]The bactericidal action of Norfloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination. Norfloxacin is a broad-spectrum antibiotic that is active against both gram-positive and gram-negative bacterias. The fluorine atom at the 6 position increases potency against gram-negative organisms, and the piperazine moiety at the 7 position is responsible for anti-pseudomonal activity J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 232 CONFIDENCE standard compound; INTERNAL_ID 1032

   

Tryptophyl-Aspartate

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}butanedioate

C15H17N3O5 (319.1168)


Tryptophyl-Aspartate is a dipeptide composed of tryptophan and aspartate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Aspartyl-Tryptophan

3-Amino-3-{[1-carboxy-2-(1H-indol-3-yl)ethyl]-C-hydroxycarbonimidoyl}propanoate

C15H17N3O5 (319.1168)


Aspartyl-Tryptophan is a dipeptide composed of aspartate and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

4-Hydroxy-5-[3-[(1-methylcyclohexyl)methoxy]phenyl]-3H-1,3-thiazol-2-one

4-hydroxy-5-{3-[(1-methylcyclohexyl)methoxy]phenyl}-2,3-dihydro-1,3-thiazol-2-one

C17H21NO3S (319.1242)


   
   
   
   
   

2-chloro-3-(octylamino)-1,4-dihydronaphthalene-1,4-dione

2-chloro-3-(octylamino)-1,4-dihydronaphthalene-1,4-dione

C18H22ClNO2 (319.1339)


   

6-methoxy-N-[2-(trifluoromethyl)phenyl]-3,4-dihydro-2H-naphthalen-1-imine

6-methoxy-N-[2-(trifluoromethyl)phenyl]-3,4-dihydro-2H-naphthalen-1-imine

C18H16F3NO (319.1184)


   

Rhetsinine

1H-Pyrido(3,4-b)indol-1-one, 2,3,4,9-tetrahydro-2-(2-(methyamino)benzoyl)-

C19H17N3O2 (319.1321)


   

4,5-Dehydroguadiscine

4,5-Dehydroguadiscine

C20H17NO3 (319.1208)


   

1-N-beta-D-ribofuranosylmakaluvamine I|N-1-beta-D-ribofuranosylmakalucamine I|N-1-beta-D-ribofuranosylmakaluvamine I

1-N-beta-D-ribofuranosylmakaluvamine I|N-1-beta-D-ribofuranosylmakalucamine I|N-1-beta-D-ribofuranosylmakaluvamine I

C15H17N3O5 (319.1168)


   

Goshuyuamide II|GoshuyuamideII

Goshuyuamide II|GoshuyuamideII

C19H17N3O2 (319.1321)


   

Oidioperazine B

Oidioperazine B

C15H17N3O5 (319.1168)


   
   

Hydroxyevodiamine

7-hydroxy-21-methyl-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4(9),5,7,15,17,19-heptaen-14-one

C19H17N3O2 (319.1321)


   

Norfloxacin (Norxacin)

Norfloxacin (Norxacin)

C16H18FN3O3 (319.1332)


   

Rhetsinine_83.1\\%

Rhetsinine_83.1\\%

C19H17N3O2 (319.1321)


   

Rhetsinine_major

Rhetsinine_major

C19H17N3O2 (319.1321)


   
   
   
   
   
   
   
   
   

H-1152

5-[[(2S)-hexahydro-2-methyl-1H-1,4-diazepin-1-yl]sulfonyl]-4-methyl-isoquinoline, dihydrochloride

C16H21N3O2S (319.1354)


   

Asp-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]butanedioic acid

C15H17N3O5 (319.1168)


A dipeptide formed from L-alpha-aspartyl and L-tryptophan residues.

   

TRP-Asp

3-amino-3-{[1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C15H17N3O5 (319.1168)


A dipeptide formed from L-tryptophan and L-aspartic acid residues.

   

ETHYL5-CHLOROTHIOPHENE-2-CARBOXLATE

ETHYL5-CHLOROTHIOPHENE-2-CARBOXLATE

C17H21NO3S (319.1242)


   

(S)-(+)-N-(1-(1-NAPHTHYL)ETHYL)PHTHALAM&

(S)-(+)-N-(1-(1-NAPHTHYL)ETHYL)PHTHALAM&

C20H17NO3 (319.1208)


   

(2R)-2-[(4-Ethyl-2,3-dioxopiperazinyl)carbonylamino]-2-phenylacetic acid

(2R)-2-[(4-Ethyl-2,3-dioxopiperazinyl)carbonylamino]-2-phenylacetic acid

C15H17N3O5 (319.1168)


   

4-Aminobenzo-15-crown-5 hydrochloride

4-Aminobenzo-15-crown-5 hydrochloride

C14H22ClNO5 (319.1186)


   

3-(2-Benzyl(methyl)aminoethyl)benzoic acid methyl ester hydrochloride

3-(2-Benzyl(methyl)aminoethyl)benzoic acid methyl ester hydrochloride

C18H22ClNO2 (319.1339)


   

NAPHTHOL AS-D ACETATE

NAPHTHOL AS-D ACETATE

C20H17NO3 (319.1208)


   

2-[4-(4-hydroxybut-2-ynyl)piperazin-1-yl]-3-nitrobenzoic acid

2-[4-(4-hydroxybut-2-ynyl)piperazin-1-yl]-3-nitrobenzoic acid

C15H17N3O5 (319.1168)


   

dimethyl 4-(3-methoxy-3-oxopropyl)-4-nitroheptanedioate

dimethyl 4-(3-methoxy-3-oxopropyl)-4-nitroheptanedioate

C13H21NO8 (319.1267)


   

Y-27632 dihydrochloride

Y-27632 dihydrochloride

C14H23Cl2N3O (319.1218)


   

(1-(tert-Butoxycarbonyl)-7-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

(1-(tert-Butoxycarbonyl)-7-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

C15H18BNO6 (319.1227)


   

[4-methoxycarbonyl-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

[4-methoxycarbonyl-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

C15H18BNO6 (319.1227)


   

(1-(tert-Butoxycarbonyl)-6-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

(1-(tert-Butoxycarbonyl)-6-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

C15H18BNO6 (319.1227)


   

(1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

(1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

C15H18BNO6 (319.1227)


   

Sumanirole Maleate

Sumanirole Maleate

C15H17N3O5 (319.1168)


Sumanirole maleate (U-95666E; PNU-95666E) is a highly selective D2 receptor full agonist with an ED50 of about 46 nM. Sumanirole plays an important role in the research of Parkinson's disease and restless leg syndrome[1].

   

(R)-(-)-N-(1-(1-NAPHTHYL)ETHYL)PHTHALAMI C ACID

(R)-(-)-N-(1-(1-NAPHTHYL)ETHYL)PHTHALAMI C ACID

C20H17NO3 (319.1208)


   

9-[1,1-Biphenyl]-3-yl-9H-carbazole

9-[1,1-Biphenyl]-3-yl-9H-carbazole

C24H17N (319.1361)


   

3,6-Diphenyl-9H-carbazole

3,6-Diphenyl-9H-carbazole

C24H17N (319.1361)


   

1-BENZYL-6,7-DIMETHOXY-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROCHLORIDE

1-BENZYL-6,7-DIMETHOXY-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROCHLORIDE

C18H22ClNO2 (319.1339)


   

LCZ696 impurity 6

LCZ696 impurity 6

C18H22ClNO2 (319.1339)


   

4,5-diphenylpyrrolo[1,2-a]quinoline

4,5-diphenylpyrrolo[1,2-a]quinoline

C24H17N (319.1361)


   

1-Dansylpiperazine

1-Dansylpiperazine

C16H21N3O2S (319.1354)


   

(S)-2-Methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine

(S)-2-Methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine

C16H21N3O2S (319.1354)


   

6-Chloro-4-(cyclohexyloxy)-3-propylquinolin-2(1H)-one

6-Chloro-4-(cyclohexyloxy)-3-propylquinolin-2(1H)-one

C18H22ClNO2 (319.1339)


   

1-[1-(3-Fluorophenyl)-2,5-dioxopyrrolidin-3-yl]piperidine-4-carboxamide

1-[1-(3-Fluorophenyl)-2,5-dioxopyrrolidin-3-yl]piperidine-4-carboxamide

C16H18FN3O3 (319.1332)


   

3-O-methylentacapone

3-O-methylentacapone

C15H17N3O5 (319.1168)


   

1-Cyclohexyl-3-(6-ethoxy-1,3-benzothiazol-2-yl)urea

1-Cyclohexyl-3-(6-ethoxy-1,3-benzothiazol-2-yl)urea

C16H21N3O2S (319.1354)


   

4-[3,4-dihydro-1H-isoquinolin-2-yl(oxo)methyl]-2-methyl-1-phthalazinone

4-[3,4-dihydro-1H-isoquinolin-2-yl(oxo)methyl]-2-methyl-1-phthalazinone

C19H17N3O2 (319.1321)


   

6-Chloro-4-(cyclohexyloxy)-3-isopropylquinolin-2(1H)-one

6-Chloro-4-(cyclohexyloxy)-3-isopropylquinolin-2(1H)-one

C18H22ClNO2 (319.1339)


   

5-(2-Fluorophenyl)-N-(Pyridin-4-Ylmethyl)pyrazolo[1,5-A]pyrimidin-7-Amine

5-(2-Fluorophenyl)-N-(Pyridin-4-Ylmethyl)pyrazolo[1,5-A]pyrimidin-7-Amine

C18H14FN5 (319.1233)


   

N-(7-Carbamimidoyl-naphthalen-1-YL)-3-hydroxy-2-methyl-benzamide

N-(7-Carbamimidoyl-naphthalen-1-YL)-3-hydroxy-2-methyl-benzamide

C19H17N3O2 (319.1321)


   

6-(2-Fluorophenyl)-N-(Pyridin-3-Ylmethyl)imidazo[1,2-A]pyrazin-8-Amine

6-(2-Fluorophenyl)-N-(Pyridin-3-Ylmethyl)imidazo[1,2-A]pyrazin-8-Amine

C18H14FN5 (319.1233)


   

{2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid

{2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid

C15H17N3O5 (319.1168)


   

(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate

(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate

C17H19O6- (319.1182)


   

6-Methyl-5-[3-(3-nitrophenoxy)propoxy]pyrimidine-2,4-diamine

6-Methyl-5-[3-(3-nitrophenoxy)propoxy]pyrimidine-2,4-diamine

C14H17N5O4 (319.128)


   

N-[2-(1-azepanyl)-1,3-benzothiazol-6-yl]carbamic acid ethyl ester

N-[2-(1-azepanyl)-1,3-benzothiazol-6-yl]carbamic acid ethyl ester

C16H21N3O2S (319.1354)


   

3,5-dimethyl-1H-pyrrole-2,4-dicarboxylic acid O4-ethyl ester O2-[(2-fluorophenyl)methyl] ester

3,5-dimethyl-1H-pyrrole-2,4-dicarboxylic acid O4-ethyl ester O2-[(2-fluorophenyl)methyl] ester

C17H18FNO4 (319.122)


   

N-(2-furanylmethyl)-1-(4-methoxyphenyl)-5-benzimidazolamine

N-(2-furanylmethyl)-1-(4-methoxyphenyl)-5-benzimidazolamine

C19H17N3O2 (319.1321)


   

2-(4-Methoxyphenyl)-5-[(2-phenylethyl)amino]-1,3-oxazole-4-carbonitrile

2-(4-Methoxyphenyl)-5-[(2-phenylethyl)amino]-1,3-oxazole-4-carbonitrile

C19H17N3O2 (319.1321)


   

2-(9-Ethyl-6-indolo[3,2-b]quinoxalinyl)acetic acid methyl ester

2-(9-Ethyl-6-indolo[3,2-b]quinoxalinyl)acetic acid methyl ester

C19H17N3O2 (319.1321)


   

7,8-Dimethoxy-5-methyl-3-phenylpyrazolo[3,4-c]isoquinoline

7,8-Dimethoxy-5-methyl-3-phenylpyrazolo[3,4-c]isoquinoline

C19H17N3O2 (319.1321)


   

N-(4-fluorophenyl)-1-(3-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinamine

N-(4-fluorophenyl)-1-(3-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinamine

C18H14FN5 (319.1233)


   

1-(4-Methoxyanilino)-3-(4-methoxyphenyl)sulanylpropan-2-ol

1-(4-Methoxyanilino)-3-(4-methoxyphenyl)sulanylpropan-2-ol

C17H21NO3S (319.1242)


   

6-(2-methyl-3-furanyl)-N-[(5-methyl-2-furanyl)methyl]-4-quinazolinamine

6-(2-methyl-3-furanyl)-N-[(5-methyl-2-furanyl)methyl]-4-quinazolinamine

C19H17N3O2 (319.1321)


   

6-(1,3-benzodioxol-5-yl)-N-(cyclopropylmethyl)-4-quinazolinamine

6-(1,3-benzodioxol-5-yl)-N-(cyclopropylmethyl)-4-quinazolinamine

C19H17N3O2 (319.1321)


   

1-Cyclopropyl-4-oxo-5-methyl-6-fluoro-7-[(2-aminoethyl)amino]-1,4-dihydroquinoline-3-carboxylic acid

1-Cyclopropyl-4-oxo-5-methyl-6-fluoro-7-[(2-aminoethyl)amino]-1,4-dihydroquinoline-3-carboxylic acid

C16H18FN3O3 (319.1332)


   

2-(1-Ethyl-1H-indol-2-yl)-1-methyl-1H-benzimidazole-6-carboxylic acid

2-(1-Ethyl-1H-indol-2-yl)-1-methyl-1H-benzimidazole-6-carboxylic acid

C19H17N3O2 (319.1321)


   

5-(1,4-Diazepan-1-ylsulfonyl)-4-ethylisoquinoline

5-(1,4-Diazepan-1-ylsulfonyl)-4-ethylisoquinoline

C16H21N3O2S (319.1354)


   

N-[(3,4-dimethoxyphenyl)methyl]-3-(2-pyrimidinylthio)-1-propanamine

N-[(3,4-dimethoxyphenyl)methyl]-3-(2-pyrimidinylthio)-1-propanamine

C16H21N3O2S (319.1354)


   
   
   
   
   
   
   

N-acetylmethionylglutamine

N-acetylmethionylglutamine

C12H21N3O5S (319.1202)


   

3-Methyl-4-phenacyl-1-para-tolyl-3-pyrroline-2,5-dione

3-Methyl-4-phenacyl-1-para-tolyl-3-pyrroline-2,5-dione

C20H17NO3 (319.1208)


   

norfloxacin

norfloxacin

C16H18FN3O3 (319.1332)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

   

Mycophenolate

Mycophenolate

C17H19O6 (319.1182)


A monocarboxylic acid anion resulting from the removal of a proton from the carboxy group of mycophenolic acid.

   

Neuropeptide Y5 receptor ligand-1

Neuropeptide Y5 receptor ligand-1

C19H17N3O2 (319.1321)


Neuropeptide Y5 receptor ligand-1 (compound 54), a carbazole derivative, is a potent neuropeptide Y5 (NPY-5) receptor antagonist[1].

   

(2z)-n-(4-{[(2e)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

(2z)-n-(4-{[(2e)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

C17H21NO3S (319.1242)


   

10-{[2-(4-hydroxyphenyl)ethenyl]amino}-2-methyl-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

10-{[2-(4-hydroxyphenyl)ethenyl]amino}-2-methyl-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

C19H17N3O2 (319.1321)


   

2-hydroxy-3-(1h-indol-3-ylmethyl)-4-methyl-3h-1,4-benzodiazepin-5-one

2-hydroxy-3-(1h-indol-3-ylmethyl)-4-methyl-3h-1,4-benzodiazepin-5-one

C19H17N3O2 (319.1321)


   

n-(4-{[3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

n-(4-{[3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

C17H21NO3S (319.1242)


   

10-amino-2-[(3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

10-amino-2-[(3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

C15H17N3O5 (319.1168)


   

2-[2-(methylamino)benzoyl]-3h,4h,9h-pyrido[3,4-b]indol-1-one

2-[2-(methylamino)benzoyl]-3h,4h,9h-pyrido[3,4-b]indol-1-one

C19H17N3O2 (319.1321)


   

10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2-methyl-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2-methyl-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

C19H17N3O2 (319.1321)


   

(2e)-n-(4-{[(2e)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

(2e)-n-(4-{[(2e)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

C17H21NO3S (319.1242)


   

3-[2-(1h-indol-3-yl)ethyl]-1-methylquinazoline-2,4-dione

3-[2-(1h-indol-3-yl)ethyl]-1-methylquinazoline-2,4-dione

C19H17N3O2 (319.1321)


   

(2e)-n-(4-{[(2z)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

(2e)-n-(4-{[(2z)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

C17H21NO3S (319.1242)


   

4-[2-({11-hydroxy-7-methyl-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,8(12),9-tetraen-10-yl}imino)ethylidene]cyclohexa-2,5-dien-1-one

4-[2-({11-hydroxy-7-methyl-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,8(12),9-tetraen-10-yl}imino)ethylidene]cyclohexa-2,5-dien-1-one

C19H17N3O2 (319.1321)


   

(3s)-2-hydroxy-3-(1h-indol-3-ylmethyl)-4-methyl-3h-1,4-benzodiazepin-5-one

(3s)-2-hydroxy-3-(1h-indol-3-ylmethyl)-4-methyl-3h-1,4-benzodiazepin-5-one

C19H17N3O2 (319.1321)


   

16-methoxy-13,13-dimethyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaene

16-methoxy-13,13-dimethyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaene

C20H17NO3 (319.1208)


   

n-(2-{12-hydroxy-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-10-yl}ethyl)ethanimidic acid

n-(2-{12-hydroxy-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-10-yl}ethyl)ethanimidic acid

C19H17N3O2 (319.1321)


   

3,5-dihydroxy-4-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanoic acid

3,5-dihydroxy-4-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanoic acid

C13H21NO8 (319.1267)


   

5,6-dihydroxy-3-(hydroxymethyl)-6-(1h-indol-3-ylmethyl)-1-methoxy-3h-pyrazin-2-one

5,6-dihydroxy-3-(hydroxymethyl)-6-(1h-indol-3-ylmethyl)-1-methoxy-3h-pyrazin-2-one

C15H17N3O5 (319.1168)